参考文献/References:
[1] Govindan R, Page N, Morgensztern D, et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years:analysis of the surveillance, epidemiologic, and end results database[J]. J Clin Oncol, 2006, 24(28):4539-4544. DOI:10.1200/JCO.2005.04.4859.
[2] van Meerbeeck JP, Fennell DA, De Ruysscher DK. Small-cell lung cancer[J]. Lancet, 2011, 378(9804):1741-1755. DOI:10.1016/S0140-6736(11)60165-7.
[3] Vallières E, Shepherd FA, Crowley J, et al. The IASLC Lung Cancer Staging Project:proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer[J]. J Thoracic Oncol, 2009, 4(9):1049-1059. DOI:10.1097/JTO.0b013 e3181b27799.
[4] Karve SJ, Price GL, Davis KL, et al. Comparison of demographics, treatment patterns, health care utilization, and costs among elderly patients with extensive-stage small cell and metastatic non-small cell lung cancers[J/OL]. BMC Health Serv Res, 2014, 14:555[2017-12-04]. https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25392276. DOI:10.1186/s12913-014-0555-8.
[5] Fiegl M, Pircher A, Waldthaler C, et al. Small steps of improvement in small-cell lung cancer(SCLC) within two decades:a comprehensive analysis of 484 patients[J]. Lung Cancer, 2014, 84(2):168-174. DOI:10.1016/j.lungcan.2014.02.005.
[6] Kalemkerian GP. Running in place:the 20th anniversary of the NCCN small cell lung cancer guidelines panel[J]. JNatl Compr Canc Netw, 2015, 13(6):704-706. DOI:10.6004/jnccn.2015.0084.
[7] Eckert F, Müller AC. SCLC extensive disease-treatment guidance by extent or/and biology of response?[J/OL]. Radiat Oncol, 2008, 3:33[2017-12-04]. https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18831728. DOI:10.1186/1748-717X-3-33.
[8] Socinski MA, Bogart JA. Limited-stage small-cell lung cancer:the current status of combined-modality therapy[J]. J Clin Oncol, 2007, 25(26):4137-4145. DOI:10.1200/JCO.2007.11.5303.
[9] Jeremic B, Shibamoto Y, Nikolic N, et al. Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer:A randomized study[J]. J Clin Oncol, 1999, 17(7):2092-2099. DOI:10.1200/JCO.1999.17.7.2092.
[10] Giuliani ME, Atallah S, Sun A, et al. Clinical outcomes of extensive stage small cell lung carcinoma patients treated with consolidative thoracic radiotherapy[J]. Clin Lung Cancer, 2011, 12(6):375-379. DOI:10.1016/j.cllc.2011.03.028.
[11] Zhu H, Zhou Z, Wang Y, et al. Thoracic radiation therapy improves the overall survival of patients with extensive-stage small cell lung cancer with distant metastasis[J]. Cancer, 2011, 117(23):5423-5431. DOI:10.1002/cncr.26206.
[12] Gore EM, Hu C, Sun AY, et al. Randomized phase Ⅱ study comparing prophylactic cranial irradiation alone to prophylactic cranial irradiation and consolidative extracranial irradiation for extensive-disease small cell lung cancer (ED SCLC):NRG oncology RTOG 0937[J]. J Thorac Oncol, 2017, 12(10):1561-1570. DOI:10.1016/j.jtho.2017.06.015.
[13] Slotman BJ, van Tinteren H, Praag JO, et al. Use of thoracic radiotherapy for extensive stage small-cell lung cancer:a phase 3 randomised controlled trial[J]. Lancet, 2015, 385(9962):36-42.DOI:10.1016/S0140-6736(14)61085-0.
[14] Bremnes RM, Sundstrom S, Aaseb?U, et al. The value of prognostic factors in small cell lung cancer:results from a randomised multicenter study with minimum 5 year follow-up[J]. Lung Cancer, 2003, 39(3):303-313. DOI:10.1016/S0169-5002(02)00508-1.
[15] 张文珏, 周宗玫, 陈东福, 等. 广泛期SCLC化疗后IMRT的疗效分析[J]. 中华放射肿瘤学杂志, 2016, 25(1):14-17. DOI:10.3760/cma.j.issn.1004-4221.2016.01.004. Zhang WJ, Zhou ZM, Chen DF, et al. Clinical outcomes of extensive stage small cell lung cancer patients treated with intensive modified radiotherapy[J]. Chin J Radiat Oncol, 2016, 25(1):14-17.
[16] Yee D, Butts C, Reiman A, et al. Clinical trial of post-chemotherapy consolidation thoracic radiotherapy for extensive-stage small cell lung cancer[J]. Radiother Oncol, 2012, 102(2):234-238. DOI:10.1016/j.radonc.2011.08.042.
相似文献/References:
[1]麦卫平,张永林.能谱CT成像在肺癌诊断中的应用研究进展[J].国际放射医学核医学杂志,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
Mai Weiping,Zhang Yonglin.Research progress of spectral imaging in the diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
[2]李景涛,邓垒,张文珏,等.广泛期小细胞肺癌胸部IMRT后发生放射性肺炎的危险因素分析[J].国际放射医学核医学杂志,2016,40(2):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
Li Jingtao,Deng Lei,Zhang Wenjue,et al.Risk factor analysis for predicting radiation pneumonitis in extensive stage small cell lung cancer patients receiving IMRT thoracic radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
[3]霍小东,王慧星,阎卫亮,等.血管内皮抑制素对125I近距离照射裸鼠肺癌移植瘤的增敏效应研究[J].国际放射医学核医学杂志,2016,40(5):357.[doi:10.3760/cma.j.issn.1673-4114.2016.05.006]
Huo Xiaodong,Wang Huixing,Yan Weiliang,et al.Sensitization effect of endostatin for 125I brachytherapy on transplanted tumor in nude mice[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):357.[doi:10.3760/cma.j.issn.1673-4114.2016.05.006]
[4]张毓艺,姚稚明.18F-FDG PET/CT对非小细胞肺癌淋巴结分期诊断价值的研究进展[J].国际放射医学核医学杂志,2016,40(6):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]
Zhang Yuyi,Yao Zhiming.The progress of 18F-FDG PET/CT in the diagnosis of N-staging of non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]
[5]张艳兰,孙琦婷,武萍,等.呼吸门控PET/CT对于肺癌放疗靶区勾画的指导[J].国际放射医学核医学杂志,2015,39(2):105.[doi:10.3760/cma.j.issn.1673-4114.2015.02.001]
Zhang Yanlan,Sun Qiting,Wu Ping,et al.Guiding the target delineation in radiation therapy of lung cancer by respiratory gated PET/CT[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):105.[doi:10.3760/cma.j.issn.1673-4114.2015.02.001]
[6]万绪明,许祖闪,侯红军.磁共振表观弥散系数变化率对肝细胞肝癌患者单次TACE术后疗效评价的应用价值[J].国际放射医学核医学杂志,2015,39(2):129.[doi:10.3760/cma.j.issn.1673-4114.2015.02.006]
Wan Xuming,Xu Zushan,Hou Hongjun.Applieation value of the change ratio of apparent diffusion coefficient in the therapeutic evaluation of hepatocellular carcinoma treated by single transcatheter arterial chemoembolization[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):129.[doi:10.3760/cma.j.issn.1673-4114.2015.02.006]
[7]王振光,王洋洋.PET/CT显像在肝细胞肝癌诊断中的研究进展[J].国际放射医学核医学杂志,2015,39(2):175.[doi:10.3760/cma.j.issn.1673-4114.2015.02.016]
Wang Zhenguang,Wang Yangyang.The development of PET/CT imaging in the diagnosis of hepatocellular carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):175.[doi:10.3760/cma.j.issn.1673-4114.2015.02.016]
[8]张高潮,马丽,寇莹,等.99Tcm-tetrofosmin SPECT诊断肺部肿瘤的临床价值[J].国际放射医学核医学杂志,2015,39(4):303.[doi:10.3760/cma.j.issn.1673-4114.2015.04.007]
Zhang Gaochao,Ma Li,Kou Ying,et al.Clinical value of 99Tcm-tetrofosmin SPECT in the diagnosis of lung neoplasms[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):303.[doi:10.3760/cma.j.issn.1673-4114.2015.04.007]
[9]付畅,史大鹏,徐俊玲,等.不同组织学类型肺癌患者大脑静息葡萄糖代谢改变研究[J].国际放射医学核医学杂志,2014,38(2):75.[doi:10.3760/cma.j.issn.1673-4114.2014.02.002]
Fu Chang,Shi Dapeng,Xu Junling,et al.The preliminary study of brain glucose metabolism changes in patients with lung cancer of different histological types[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(1):75.[doi:10.3760/cma.j.issn.1673-4114.2014.02.002]
[10]张俊涛.晚期肺癌125I粒子植入治疗近期疗效观察[J].国际放射医学核医学杂志,2014,38(2):94.[doi:10.3760/cma.j.issn.1673-4114.2014.02.006]
Zhang Juntao.Short-term efficacy of 125I seeds implantation in the treatment of advanced lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(1):94.[doi:10.3760/cma.j.issn.1673-4114.2014.02.006]
[11]董佳丽,罗丹,李源,等.降低B7-H3蛋白对受照肺癌细胞A549细胞周期和凋亡的影响[J].国际放射医学核医学杂志,2017,41(3):193.[doi:10.3760/cma.j.issn.1673-4114.2017.03.007]
Dong Jiali,Luo Dan,Li Yuan,et al.Study on the effects of B7-H3 down-regulation on cell cycle and apoptosis of lung cancer A549 cells[J].International Journal of Radiation Medicine and Nuclear Medicine,2017,41(1):193.[doi:10.3760/cma.j.issn.1673-4114.2017.03.007]